KLOW 80mg
Product Information
Label / Documentation
Verify Amino Research product information and COA documentation through the Amino Research verification page at aminoresearch.net.
KLOW 80mg
KLOW 80mg is a four-component catalog blend with a labeled total of 80mg: BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, and KPV 10mg, as specified in the linked report. Published sources separately discuss BPC-157 tendon-explant and fibroblast experiments, thymosin beta-4 rat and keratinocyte models, GHK-Cu laboratory and gene-expression research, and KPV transport, cell, and mouse studies.
These sources concern separate components and experimental systems, not this blend. Thymosin beta-4 literature does not establish TB-500 identity. The sources do not establish combined effects, safety, efficacy, an approved indication, or suitability for human or animal use. This material is supplied only for laboratory research, with no dosing or administration guidance.
Documentation note: Horizon Analytical report 1031628, analyzed October 16, 2026, provides separate UPLC/MS tested-content and purity results for four components of lot DPS-8846635. The original eight-page PDF is unchanged. No endotoxin result is reported for this lot. No aggregate purity or tested-content total is inferred.
Research sources
- Chang et al.: BPC-157 in tendon explants and fibroblasts — rat tendon explants and cultured-fibroblast assays.
- Malinda et al.: thymosin beta-4 in rat and keratinocyte models — related thymosin beta-4 research; not evidence of TB-500 identity or blend effects.
- Pickart and Margolina: GHK-Cu laboratory and gene-data review — review of laboratory, animal-model, fibroblast, and gene-expression studies.
- Dalmasso et al.: PepT1-mediated tripeptide KPV uptake — intestinal epithelial cells, immune cells, transport assays, and mouse models.
Documentation and related records
Documentation status: Purity-only COA.
Review the current KLOW 80mg documentation for lot DPS-8846635, the testing and COA guidance, and the Research Use Only compliance information. For adjacent catalog records, see GLOW 70mg, GHK-CU 100mg, KPV 10mg. These links support catalog navigation and do not imply equivalence or use.
KLOW 80mg — Specifications
Testing & documentation for KLOW 80mg
The current combined third-party report identifies KLOW 80mg for lot DPS-8846635 and reports tested content and purity separately for each listed component. Endotoxin: Not reported on the current COA. No aggregate component total or purity is inferred; researchers should review the literal component results and documentation note.
Only documented test categories are shown. Where a value is not yet published it is shown as “Available on documentation” or “Pending.”
For laboratory research use only
KLOW 80mg is intended solely for laboratory research use by qualified research professionals. It is not for human or animal consumption and is not intended for diagnostic, therapeutic, or clinical use. No dosing or administration guidance is provided. Researchers are responsible for compliance with all applicable laws and regulations. Review Amino Research compliance and RUO information.
How Amino Research materials are supplied
Purity-only COA
Current documentation identifies lot DPS-8846635 for this KLOW 80mg record.
Component-Specific Purity
The current report lists a separate UPLC/MS purity result for each component.
Component Test Results
Labeled content and literal tested-content results are disclosed separately for every component.
RUO Documentation
COA access and clear research-only limitations are linked from this product record.
KLOW 80mg
Add this research-use material to your cart, or review its documentation. Pricing reflects current Amino Research pricing.
In stock — ready to ship
⇩ Download COA (PDF)KLOW 80mg — FAQ
What research context is available for the components listed in the KLOW record?
Separate sources discuss BPC-157 in tendon explants and fibroblasts, thymosin beta-4 in rat and keratinocyte models, GHK-Cu laboratory research, and KPV cell and mouse systems. The thymosin beta-4 source does not establish TB-500 identity, and none of the sources establishes combined effects or an approved use for KLOW.
What does the current KLOW 80mg COA document?
The current third-party report for lot DPS-8846635 provides component-specific results: BPC-157 — labeled 10 mg, tested content 9.86 mg, purity 99.32%; TB-500 — labeled 10 mg, tested content 9.81 mg, purity 99.32%; GHK-Cu — labeled 50 mg, tested content 50.51 mg, purity 99.65%; KPV — labeled 10 mg, tested content 9.84 mg, purity 99.21%. Endotoxin: Not reported on the current COA. No numeric endotoxin value is inferred. No aggregate purity or tested-content total is inferred. Documentation note: Horizon Analytical report 1031628, analyzed October 16, 2026, provides separate UPLC/MS tested-content and purity results for four components of lot DPS-8846635. The original eight-page PDF is unchanged. No endotoxin result is reported for this lot. No aggregate purity or tested-content total is inferred. Review the complete lot-specific PDF.
How should researchers verify this documentation?
Match the product name and lot on the vial to the report, then review the method, purity, tested content, endotoxin result, and report date. See the testing and COA guidance and the COA Library.
Is KLOW 80mg intended for human or animal use?
No. It is supplied solely for laboratory research use by qualified research professionals. It is not for human or animal consumption and is not intended for diagnostic, therapeutic, or clinical use. No dosing or administration guidance is provided. Review the RUO and compliance information.
Which related Amino Research records can be reviewed?
Researchers can review GLOW 70mg, GHK-CU 100mg, KPV 10mg. These links are provided for catalog navigation, not as equivalence or use claims.
Lab Documentation & Batch Records
Amino Research retains identity, purity, and endotoxin documentation organized by lot, and adds new records as additional batches are tested. The newest report is the current documentation; earlier reports are retained as batch history. Third-party tested. For laboratory research use only.
| Product | Lot / Batch | Test Type | Report date | Status | Report |
|---|---|---|---|---|---|
| KLOW 80mg | DPS-8846635 | Purity | Analysis: Oct 16, 2026 | Current | View PDF |
| KLOW 80mg | HEL-7626298 | Purity + Endotoxin | Received: Jun 29, 2026 | Archived | View PDF |
| KLOW 80mg | HEL-1551352 | Purity | Received: Jun 12, 2026 | Archived | View PDF |
| KLOW 80mg | On file | Purity | Received: On file | Archived | View PDF |
Research Use Only. Documentation is provided for identity and quality verification for laboratory research use only. Not for human or animal consumption.
Review this product’s documentation
Match the product name, strength and lot identifier before comparing test results. Read the COA and batch documentation guide.
